Cardiovascular Disease Prevalence and Related Outcomes in Nigeria: A Critical Review of Evidence, Measurement Gaps and Care Outcomes

Olofin-Samuel, Mary Ayodeji *

Department of Nursing, Faculty of Basic Medical Sciences, Ekiti State University, Ado-Ekiti, Nigeria.

Ayo-Oluwaseyi, Temitope Grace

Department of Nursing Science, Faculty of Basic Medical Sciences, Ekiti State University, Ado-Ekiti, Nigeria.

Odiru, Anuoluwa Deborah

Department of Nursing Science, Faculty of Basic Medical Sciences, Ekiti State University, Ado-Ekiti, Nigeria.

Awolumate, Deborah Adebimpe

Faculty of Nursing Science, Afe Babalola University, Ado-Ekiti, Nigeria.

Ojo, Taiwo Folake

Department of Nursing Science, Faculty of Basic Medical Sciences, Ekiti State University, Ado-Ekiti, Nigeria.

Gentry Oluwabukola Ayo

Department of Nursing Science, Faculty of Basic Medical Sciences, Ekiti State University, Ado-Ekiti, Nigeria.

Ige, Waleola Bukola

Faculty of Nursing Science, Federal University, Oye-Ekiti, Ekiti State, Nigeria.

*Author to whom correspondence should be addressed.


Abstract

Background: Nigeria is the most populous country in Africa and is passing through an epidemiological transition in which cardiovascular disease is assuming a larger share of adult morbidity, disability and premature death. Estimates of that burden nevertheless vary widely, and their reliability is rarely examined alongside the outcomes that matter to patients and health systems.

Purpose and Scope: This critical narrative review appraises evidence on the prevalence, incidence and related outcomes of adult cardiovascular disease in Nigeria, covering hypertension, stroke, heart failure and cardiomyopathies, rheumatic and other valvular disease, atrial fibrillation, coronary heart disease, the principal cardiometabolic risk factors, and mortality, economic and health-system outcomes.

Methods: Peer-reviewed literature and institutional reports were identified through structured searches of international and African bibliographic sources, supplemented by citation tracking. Studies were appraised qualitatively for sampling frame, case ascertainment, outcome completeness and analytical transparency, and the findings were synthesised thematically.

Principal Findings: Hypertension is the dominant and best-documented condition, affecting roughly one in three adults, with a narrowing urban–rural gradient and very low population-level control. It underlies most stroke, heart failure and sudden cardiac death in Nigerian series. Stroke carries high early case fatality, and heart failure affects relatively young adults with predominantly hypertensive aetiology. Peripartum cardiomyopathy shows a striking concentration in the North-West. Coronary heart disease appears to be rising, but its burden remains uncertain because diagnostic capacity is limited. Much of the evidence is hospital-based, regionally clustered and methodologically heterogeneous, and population-level mortality data remain scarce.

Unresolved Questions: True incidence trends, cause-specific mortality, long-term outcomes after stroke and heart failure, and the scalability of primary-care hypertension programmes remain poorly characterised.

Implications: Priorities include a standardised national cardiovascular surveillance platform linked to civil registration and verbal autopsy, population-based stroke and heart failure registries, financial protection for chronic cardiovascular care, and sustained investment in primary-care hypertension control.

Conclusion: The evidence supports treating hypertension control as the central lever for reducing cardiovascular harm in Nigeria, while emphasising that current burden estimates rest on fragile and uneven data.

Keywords: Hypertension, stroke, heart failure, peripartum cardiomyopathy, epidemiological transition, case fatality, sub-Saharan Africa, health system


How to Cite

Ayodeji, Olofin-Samuel, Mary, Ayo-Oluwaseyi, Temitope Grace, Odiru, Anuoluwa Deborah, Awolumate, Deborah Adebimpe, Ojo, Taiwo Folake, Gentry Oluwabukola Ayo, and Ige, Waleola Bukola. 2026. “Cardiovascular Disease Prevalence and Related Outcomes in Nigeria: A Critical Review of Evidence, Measurement Gaps and Care Outcomes”. Journal of Advances in Medical and Pharmaceutical Sciences 28 (11):124-52. https://doi.org/10.9734/jamps/2026/v28i11912.

Downloads

Download data is not yet available.